Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Open-Label, Active-Controlled, Multi-Center Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer: The STAAR STUDY

Next Previous
X
Search
Trial Profile

A Randomized, Open-Label, Active-Controlled, Multi-Center Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer: The STAAR STUDY

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 18 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Abiraterone acetate (Primary) ; Methylprednisolone; Prednisone
  • Indications Adenocarcinoma; Prostate cancer
  • Focus Pharmacodynamics; Registrational
  • Acronyms STAAR
  • Sponsors Churchill Pharmaceuticals; Sun Pharma Global FZE

    • Most Recent Events

    • 23 May 2018 According to a Sun Pharmaceutical Industries media release, based on the data of this study, the U.S. Food and Drug Administration has approved YONSA (abiraterone acetate), a novel formulation in combination with methylprednisolone, for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC).
    • 10 Feb 2018 Results of subgroup analysis assessing pharmacokinetic parameters presented at the 2018 Genitourinary Cancers Symposium.
    • 06 Feb 2018 According to a Churchill Pharmaceuticals media release, the results of the study will be presented at the 2018 American Society of Clinical Oncology, Genitourinary Cancers Symposium (ASCO GU).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top